Sharon B. Wigal
About
Sharon B. Wigal is a scholar working on Psychiatry and Mental health, Developmental and Educational Psychology and Cognitive Neuroscience.
According to data from OpenAlex, Sharon B. Wigal has authored 108 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Psychiatry and Mental health, 37 papers in Developmental and Educational Psychology and 31 papers in Cognitive Neuroscience. Recurrent topics in Sharon B. Wigal's work include Attention Deficit Hyperactivity Disorder (99 papers), Child and Adolescent Psychosocial and Emotional Development (26 papers) and Bipolar Disorder and Treatment (23 papers). Sharon B. Wigal is often cited by papers focused on Attention Deficit Hyperactivity Disorder (99 papers), Child and Adolescent Psychosocial and Emotional Development (26 papers) and Bipolar Disorder and Treatment (23 papers). Sharon B. Wigal collaborates with scholars based in United States, Canada and United Kingdom. Sharon B. Wigal's co-authors include James M. Swanson, Laurence L. Greenhill, Scott H. Kollins, Marc Lerner, Tim Wigal, James J. McGough, Joseph Biederman, Ann Childress, Kelly Posner and Suneel Gupta and has published in prestigious journals such as PEDIATRICS, Journal of the American Academy of Child & Adolescent Psychiatry and Neuropsychologia.
In The Last Decade
Sharon B. Wigal
106 papers receiving 3.8k citations
Peers
Sharon B. Wigal
Charles D. Casat United States
Megan Aleardi United States
F.R. Sallee United States
Jefferson B. Prince United States
Andrew J. Cutler United States
Haruo Kashima Japan
Adelaide S. Robb United States
Robert L. Sprague United States
Anne Halmøy Norway
Jeffrey Sverd United States
Citations per year, relative to Sharon B. Wigal Sharon B. Wigal (= 1×)
peers
Charles D. Casat
Countries citing papers authored by Sharon B. Wigal
Since
Specialization
Citations
This map shows the geographic impact of Sharon B. Wigal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon B. Wigal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon B. Wigal more than expected).
Fields of papers citing papers by Sharon B. Wigal
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sharon B. Wigal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon B. Wigal. The network helps show where Sharon B. Wigal may publish in the future.
Co-authorship network of co-authors of Sharon B. Wigal
This figure shows the co-authorship network connecting the top 25 collaborators of Sharon B. Wigal. A scholar is included among the top collaborators of Sharon B. Wigal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon B. Wigal. Sharon B. Wigal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Markowitz, Jessica T., et al.. (2020). <p>Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder</p>. Neuropsychiatric Disease and Treatment. Volume 16. 1619–1643.
2.
Wigal, Sharon B., et al.. (2020). Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 30(2). 104–118.
3.
Wigal, Sharon B., Tim Wigal, Mary Hobart, et al.. (2020). <p>Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies</p>. Neuropsychiatric Disease and Treatment. Volume 16. 1411–1426.
4.
Wigal, Sharon B., Ann Childress, Susan A. Berry, et al.. (2018). Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology. 28(5). 314–321.
5.
Childress, Ann, et al.. (2017). Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 28(5). 306–313.
6.
Shaywitz, Sally E., Bennett A. Shaywitz, Linda Wietecha, et al.. (2016). Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 27(1). 19–28.
7.
Teuscher, Nathan S., Akwete Adjei, Robert L. Findling, et al.. (2015). Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder. Drug Design Development and Therapy. 9. 2767–2767.
8.
Adjei, Akwete, Nathan S. Teuscher, Robert Kupper, et al.. (2014). Single-Dose Pharmacokinetics of Methylphenidate Extended-Release Multiple Layer Beads Administered as Intact Capsule or Sprinkles Versus Methylphenidate Immediate-Release Tablets (Ritalin ® ) in Healthy Adult Volunteers. Journal of Child and Adolescent Psychopharmacology. 24(10). 570–578.
9.
Surampalli, Abhilasha, Brian T. Gold, Charles Smith, et al.. (2014). A case report comparing clinical, imaging and neuropsychological assessment findings in twins discordant for the VCP p.R155C mutation. Neuromuscular Disorders. 25(2). 177–183.
10.
Wigal, Sharon B., et al.. (2013). NWP06, an Extended-Release Oral Suspension of Methylphenidate, Improved Attention-Deficit/Hyperactivity Disorder Symptoms Compared with Placebo in a Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology. 23(1). 3–10.
11.
Kollins, Scott H., Frank A. López, Bradley Vince, et al.. (2011). Psychomotor Functioning and Alertness with Guanfacine Extended Release in Subjects with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 21(2). 111–120.
12.
Wigal, Sharon B., Tim Wigal, Sabrina Schuck, et al.. (2011). Academic, Behavioral, and Cognitive Effects of OROS ® Methylphenidate on Older Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 21(2). 121–131.
13.
Wigal, Sharon B., et al.. (2011). Pharmacokinetics and Therapeutic Effect of OROS ® Methylphenidate Under Different Breakfast Conditions in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 21(3). 255–263.
14.
Wigal, Sharon B.. (2009). Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults. CNS Drugs. 23(Supplement 1). 21–31.
15.
Pierce, David M., et al.. (2008). Pharmacokinetics of Methylphenidate Transdermal System (MTS): Results from a Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology. 18(4). 355–364.
16.
Ghuman, Jaswinder K., Mark A. Riddle, Benedetto Vitiello, et al.. (2007). Comorbidity Moderates Response to Methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 563–579.
17.
Abikoff, Howard, Benedetto Vitiello, Mark A. Riddle, et al.. (2007). Methylphenidate Effects on Functional Outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). Journal of Child and Adolescent Psychopharmacology. 17(5). 581–592.
18.
Wigal, Sharon B., Suneel Gupta, Laurence L. Greenhill, et al.. (2007). Pharmacokinetics of Methylphenidate in Preschoolers with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 17(2). 153–164.
19.
Arnold, L. Eugene, Ronald L. Lindsay, C. Keith Conners, et al.. (2004). ADouble-Blind, Placebo-Controlled Withdrawal Trial of Dexmethylphenidate Hydrochloride in Children with Attention Deficit Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 14(4). 542–554.
20.
Wigal, Sharon B., Dan Nemet, James M. Swanson, et al.. (2003). Catecholamine Response to Exercise in Children with Attention Deficit Hyperactivity Disorder. Pediatric Research. 53(5). 756–761.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Charles D. Casat Breakdown of academic impact, for papers by Megan Aleardi Breakdown of academic impact, for papers by F.R. Sallee Breakdown of academic impact, for papers by Jefferson B. Prince Breakdown of academic impact, for papers by Andrew J. Cutler Breakdown of academic impact, for papers by Haruo Kashima Breakdown of academic impact, for papers by Adelaide S. Robb Breakdown of academic impact, for papers by Robert L. Sprague Breakdown of academic impact, for papers by Anne Halmøy Breakdown of academic impact, for papers by Jeffrey Sverd